Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 9486984.
- Also identified by PMC identifier 508665.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
CD40-CD40-ligand (CD154) interactions play a critical role in immune activation. Using replication defective adenovirus encoding mouse CD154 (Ad-CD154), we modified human chronic lymphocytic leukemia B cells to express a functional ligand for CD40. This not only induces expression of immune accessory molecules on the infected cell, but also allows it to trans-activate noninfected bystander leukemia B cells. Also, factors that impair the antigen-presenting capacity of leukemia B cells are downmodulated. Ad-CD154- infected leukemia cells are highly effective stimulators in mixed lymphocyte reactions and can induce generation of cytotoxic T lymphocytes specific for autologous nonmodified leukemia cells. As such, Ad-CD154 can induce a host antileukemia response that may have therapeutic potential.
Medical subject headings
- B-Lymphocytes
- Leukemia, Lymphocytic, Chronic, B-Cell
- Membrane Glycoproteins